rs375440874
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_006950.3(SYN1):āc.1325T>Cā(p.Leu442Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000978 in 1,186,149 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 28 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006950.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SYN1 | ENST00000295987.13 | c.1325T>C | p.Leu442Pro | missense_variant | Exon 11 of 13 | 2 | NM_006950.3 | ENSP00000295987.7 | ||
SYN1 | ENST00000340666.5 | c.1325T>C | p.Leu442Pro | missense_variant | Exon 11 of 13 | 1 | ENSP00000343206.4 | |||
SYN1 | ENST00000640721.1 | c.2T>C | p.Leu1? | start_lost | Exon 1 of 2 | 5 | ENSP00000492857.1 |
Frequencies
GnomAD3 genomes AF: 0.000520 AC: 58AN: 111639Hom.: 0 Cov.: 23 AF XY: 0.000443 AC XY: 15AN XY: 33873
GnomAD3 exomes AF: 0.000128 AC: 17AN: 132407Hom.: 0 AF XY: 0.000139 AC XY: 6AN XY: 43099
GnomAD4 exome AF: 0.0000530 AC: 57AN: 1074462Hom.: 0 Cov.: 31 AF XY: 0.0000343 AC XY: 12AN XY: 350126
GnomAD4 genome AF: 0.000528 AC: 59AN: 111687Hom.: 0 Cov.: 23 AF XY: 0.000472 AC XY: 16AN XY: 33931
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
p.Leu442Pro (CTG>CCG): c.1325 T>C in exon 11 of the SYN1 gene (NM_133499.2) The Leu442Pro missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. Although both Leucine and Proline are uncharged, non-polar amino acid residues, the gain of a Proline may affect the secondary structure of the synapsin-1 protein. Leu442Pro alters a position that is not well conserved in the protein and to our knowledge, other missense mutations have not been reported in this region of the protein. Several in-silico algorithms predict Leu442Pro may be benign, while another model suggests it may be damaging to the structure/function of the protein. Therefore, based on the currently available information, it is unclear whether Leu442Pro is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at